Peptide questions · Thymosin Beta-4

Thymosin Beta-4 side effects: what studies and users report

Reviewed Evidence: EmergingPublished by PepVault

The side effects most commonly reported for Thymosin Beta-4 are injection site reaction, fatigue and headache; the library’s evidence on it includes controlled trials in people.

The library holds no separate safety note for Thymosin Beta-4.

What is commonly reported with Thymosin Beta-4

  • Injection site reaction
  • Fatigue
  • Headache

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other healing & recovery compounds the library lists it for
EffectAlso listed for (of 18)
Injection site reaction6: TB-500, GHK-Cu, AOD-9604, Thymosin Alpha-1 and 2 more
Fatigue5: TB-500, Thymosin Alpha-1, ARA-290, Abaloparatide and 1 more
Headache6: TB-500, Linaclotide, VIP, ARA-290 and 2 more
A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Track Thymosin Beta-4 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Which Thymosin Beta-4 side effects the healing & recovery group shares

Across the 19 healing & recovery compounds in the library, the effects listed most often are headache (7 of 19), injection site reaction (7 of 19), nausea (rare) (7 of 19) and fatigue (6 of 19). Every effect on Thymosin Beta-4’s list also appears for at least one other healing & recovery compound, so nothing on it is Thymosin Beta-4’s own.

Where the Thymosin Beta-4 reports come from

The library rates the evidence on Thymosin Beta-4 as emerging: mostly preclinical, with limited human data.

Of the library’s 4 research notes on Thymosin Beta-4, 2 rest on clinical data and 2 on community reports.

Our 10 study pages on Thymosin Beta-4: 4 animal studies (mice), 1 cell study (human brain organoids), 3 randomized trials, 1 cell study (hCMEC/D3 human cerebral endothelial cells) and 1 animal study (rats).

So Thymosin Beta-4 has controlled trials in people to set its listed effects against.

What our Thymosin Beta-4 study pages report on safety

Thymosin Beta-4: no serious adverse events in healthy volunteers

Randomized trial, human, 2021: Side effects were mild to moderate. No dose caused dose-limiting toxicity, meaning side effects severe enough to stop raising the dose, and there were no serious adverse events.

Thymosin Beta-4: 42-1260 mg into a vein well tolerated for 14 days

Randomized trial, human, 2010: Side effects were uncommon, and all were mild or moderate. No one had a serious adverse event, and no dose caused side effects bad enough to stop going higher.

Questions people ask

What are the side effects of Thymosin Beta-4?

The side effects most commonly reported for Thymosin Beta-4 are injection site reaction, fatigue and headache; the library’s evidence on it includes controlled trials in people.

Do Thymosin Beta-4’s side effects come from human studies?

The library rates the evidence on Thymosin Beta-4 as emerging, and the library’s evidence on it includes controlled trials in people.

Which Thymosin Beta-4 side effects are its own?

None: each effect the library lists for Thymosin Beta-4 is listed for at least one other healing & recovery compound too.

More on Thymosin Beta-4

Track it in the app

PepVault for iPhone

Track Thymosin Beta-4 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo